NCT04094311 2026-02-17Study of Out of Specification for TisagenlecleucelNovartisPhase 3 Recruiting200 enrolled
NCT06408194 2026-02-10Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell MalignanciesStanford UniversityPhase 1 Recruiting20 enrolled
NCT03642626 2026-01-23MT2017-45: CAR-T Cell Therapy for Heme MalignanciesMasonic Cancer Center, University of MinnesotaPhase 2 Active not recruiting150 enrolled 23 charts